Evidence map›Paper›PMID 19047578›Full record

ArticleHypertension (Dallas, Tex. : 1979)2009

Possible mediators of connecting tubule glomerular feedback.

YiLin Ren, Martin A D'Ambrosio, Jeffrey L Garvin, Hong Wang, Oscar A Carretero

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Tubule-vascular feedback in renal autoregulation.American journal of physiology. Renal physiology · 2019
    Review
  8. Review
  9. Role of connecting tubule glomerular feedback in obesity related renal damage.American journal of physiology. Renal physiology · 2018
    Article
  10. Article
  11. Mechanisms of connecting tubule glomerular feedback enhancement by aldosterone.American journal of physiology. Renal physiology · 2016
    Article
  12. Article
  13. Renal autoregulation in health and disease.Physiological reviews · 2015
    Review
  14. Article
  15. Article
  16. P2 receptors in renal autoregulation.Current vascular pharmacology · 2014
    Review
  17. Article
  18. Article
  19. Connecting tubule glomerular feedback in hypertension.Hypertension (Dallas, Tex. : 1979) · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

YiLin RenDivision of Hypertension and Vascular Research, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202, USA.
Martin A D'Ambrosio
Jeffrey L Garvin
Hong Wang
Oscar A Carretero
Henry Ford Hospital · US

Funding

VASOACTIVE HORMONES IN THE REGULATION OF BLOOD PRESSUREP01HL028982 · NHLBI · HENRY FORD HOSPITAL · PI PETERSON, EDWARD LAWRENCE · 1985 to 2017
$39.8M
NHLBI NIH HHS HL28982NHLBI NIH HHS P01 HL028982
6 · The paper itself

Abstract

In the renal cortex, the connecting tubule (CNT) returns to the glomerular hilum and contacts the afferent arteriole (Af-Art). Increasing Na delivery to the CNT dilates the Af-Art by activating epithelial Na channels, a process that we call connecting tubule glomerular feedback (CTGF). However, the mediator(s) of CTGF are unknown. We tested the hypothesis that Na reabsorption by the CNT induces release of arachidonic acid metabolites that diffuse to and dilate the Af-Art. Microdissected rabbit Af-Arts and adherent CNTs were simultaneously microperfused. CTGF was measured as the increase in diameter of norepinephrine-preconstricted Af-Arts in response to switching NaCl concentration in the lumen of the CNT from 10 to 80 mmol/L. Under control conditions, CTGF was repeatable and completely reversed norepinephrine-induced vasoconstriction. In the presence of 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism, CTGF was completely blocked (-0.7+/-0.3 versus 7.3+/-0.5 microm), suggesting that arachidonic acid metabolites mediate CTGF. Because both cyclooxygenase-derived prostaglandins and epoxygenase-derived epoxyeicosatrienoic acids are known vasodilatory arachidonic acid metabolites, we tested whether indomethacin or MS-PPOH (a cyclooxygenase and an epoxygenase inhibitor) could block CTGF. Both indomethacin and MS-PPOH partially blocked CTGF (2.3+/-0.8 versus 6.5+/-0.5 microm, and 2.9+/-0.8 versus 6.6+/-1.1 microm, respectively). When combined, they completely blocked CTGF (-0.4+/-0.3 versus 6.6+/-1.1 microm). We confirmed these findings by using the epoxyeicosatrienoic acid antagonist 14,15-EEZE. The combination of indomethacin plus 14,15-EEZE completely abolished CTGF (-0.3+/-0.2 versus 8.0+/-1.0 microm). We conclude that increasing Na concentrations in the CNT stimulate release of prostaglandins and epoxyeicosatrienoic acids, which mediate CTGF.

Indexed as

5,8,11,14-Eicosatetraynoic Acid8,11,14-Eicosatrienoic AcidAmidesAnimalsArachidonic AcidArteriolesCardiovascular AgentsFeedbackIndomethacinKidney GlomerulusMicrocirculationNorepinephrineProstaglandinsRabbitsSodiumSodium Channels14,15-eicosa-5-enoic acid5,8,11,14-Eicosatetraynoic Acid8,11,14-Eicosatrienoic AcidAmidesArachidonic AcidCardiovascular AgentsIndomethacinN-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamideNorepinephrineProstaglandinsSodiumSodium ChannelsVasoconstrictor Agents

Identifiers

PMID19047578
PMCPMC2697564
OpenAlexW2083307866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.